Samuel Bates Martin

Insider Reports History

Location
Hampton, NJ
Signature
/s/ Anthony S. Marucci, attorney-in-fact for Samuel Bates Martin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Bates Martin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Celldex Therapeutics, Inc. SVP AND CFO Common Stock 28.1K $996K $35.42 14 Jun 2024 Direct
Celldex Therapeutics, Inc. SVP AND CFO Incentive Stock Option (right to buy) 81K 05 Jun 2025 Direct

Insider Reports Filed by Samuel Bates Martin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLDX Celldex Therapeutics, Inc. 05 Jun 2025 1 $0 4 09 Jun 2025 SVP AND CFO
CLDX Celldex Therapeutics, Inc. 14 Jun 2024 5 -$403K 4 18 Jun 2024 SVP AND CFO
CLDX Celldex Therapeutics, Inc. 13 Jun 2024 1 $0 4 17 Jun 2024 SVP AND CFO
CLDX Celldex Therapeutics, Inc. 30 May 2024 3 -$932K 4 03 Jun 2024 SVP AND CFO
CLDX Celldex Therapeutics, Inc. 02 Jan 2024 2 $29.9K 4 04 Jan 2024 SVP AND CFO
CLDX Celldex Therapeutics, Inc. 15 Jun 2023 1 $0 4 20 Jun 2023 SVP AND CFO
CLDX Celldex Therapeutics, Inc. 11 Aug 2022 10 -$635K 4 15 Aug 2022 SVP AND CFO
CLDX Celldex Therapeutics, Inc. 16 Jun 2022 1 $0 4 17 Jun 2022 SVP AND CFO
CLDX Celldex Therapeutics, Inc. 23 Dec 2021 5 -$359K 4 28 Dec 2021 SVP and CFO
CLDX Celldex Therapeutics, Inc. 15 Nov 2021 6 -$374K 4 17 Nov 2021 SVP and CFO
CLDX Celldex Therapeutics, Inc. 10 Aug 2021 6 -$207 4 12 Aug 2021 SVP and CFO
CLDX Celldex Therapeutics, Inc. 17 Jun 2021 1 $0 4 21 Jun 2021 SVP and CFO